Celsion Corp (CLSN.O)

CLSN.O on Consolidated Issue listed on NASDAQ Capital Market

2.69USD
27 Mar 2015
Change (% chg)

$0.03 (+1.13%)
Prev Close
$2.66
Open
$2.70
Day's High
$2.74
Day's Low
$2.66
Volume
33,204
Avg. Vol
199,197
52-wk High
$3.73
52-wk Low
$2.15

CLSN.O

Chart for CLSN.O

About

Celsion Corporation is an oncology drug development company. The company is focused on developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. Its lead program is ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $53.76
Shares Outstanding(Mil.): 19.98
Dividend: --
Yield (%): --

Financials

  CLSN.O Industry Sector
P/E (TTM): -- 137.41 40.78
EPS (TTM): -1.38 -- --
ROI: -52.24 -0.59 16.19
ROE: -79.24 -2.32 17.04
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks